SHANZER; Abraham

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHANZER; Abraham.The latest application filed is for "quantum devices comprising lanthanide complexes".

Company Profile

1.12.8

SHANZER; Abraham - Rehovot IL
SHANZER; Abraham - Rechovot IL
Shanzer; Abraham - Rishon Le Zion IL
Shanzer; Abraham - Bat Yam IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Quantum Devices Comprising Lanthanide Complexes App 20190127392 - DAYAN; Barak ; et al.	2019-05-02
Antibodies And Pharmaceutical Compositions Containing Same Useful For Inhibiting Activity Of Metalloproteins App 20180134808 - SAGI; Irit ; et al.	2018-05-17
Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins Grant 9,902,783 - Sagi , et al. February 27, 2	2018-02-27
Antibodies And Pharmaceutical Compositions Containing Same Useful For Inhibiting Activity Of Metalloproteins App 20160257765 - SAGI; Irit ; et al.	2016-09-08
Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins Grant 9,416,195 - Sagi , et al. August 16, 2	2016-08-16
Lanthanide Clusters And Methods Of Use Thereof App 20160002269 - SHANZER; Abraham ; et al.	2016-01-07
Antibodies And Pharmaceutical Compositions Containing Same Useful For Inhibiting Activity Of Metalloproteins App 20130224225 - SAGI; Irit ; et al.	2013-08-29
Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins Grant 8,486,653 - Sagi , et al. July 16, 2	2013-07-16
Antibodies And Pharmaceutical Compositions Containing Same Useful For Inhibiting Activity Of Metalloproteins App 20130030158 - SAGI; Irit ; et al.	2013-01-31
Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins Grant 8,324,355 - Sagi , et al. December 4, 2	2012-12-04
Antibodies And Pharamcetical Compositions Containing Same Useful For Inhibiting Activity Of Metalloproteins App 20100233188 - Sagi; Irit ; et al.	2010-09-16
X-ray imaging of tumors with dextran carrier of platinum compounds Grant 6,694,171 - Breskin , et al. February 17, 2	2004-02-17
Hybrid organic-inorganic semiconductor structures and sensors based thereon Grant 6,433,356 - Cahen , et al. August 13, 2	2002-08-13
Pharmaceutical compositions comprising hydroxamate derivatives for iron removal Grant 5,430,058 - Shanzer , et al. July 4, 1	1995-07-04
Extractants for the separation of transition and related metal ions Grant 5,101,066 - Shanzer , et al. March 31, 1	1992-03-31
Trishydroxamic acids Grant 4,966,997 - Shanzer , et al. October 30, 1	1990-10-30
Ionic recognition and selective response in self assembling monolayer membranes on electrodes Grant 4,964,972 - Sagiv , et al. October 23, 1	1990-10-23
Some macrocyclic compounds and their preparation Grant 4,590,005 - Shanzer , et al. May 20, 1	1986-05-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.